SE8405812L - INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM COMPOUNDS - Google Patents

INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM COMPOUNDS

Info

Publication number
SE8405812L
SE8405812L SE8405812A SE8405812A SE8405812L SE 8405812 L SE8405812 L SE 8405812L SE 8405812 A SE8405812 A SE 8405812A SE 8405812 A SE8405812 A SE 8405812A SE 8405812 L SE8405812 L SE 8405812L
Authority
SE
Sweden
Prior art keywords
compounds
intermediates
preparation
substituted
new
Prior art date
Application number
SE8405812A
Other languages
Swedish (sv)
Other versions
SE8405812D0 (en
Inventor
M Menard
A Martel
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8405812L publication Critical patent/SE8405812L/en
Publication of SE8405812D0 publication Critical patent/SE8405812D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

This invention relates to phosphorane compounds of the formula <IMG> wherein Y is hydrogen, ethyl or hydroxyethyl, Q is phenyl or (lower) alkyl, R" is an easily removable ester group and X represents certain organic substituents. Also included in the invention are pharmaceutically acceptable salts of the above compounds and derivatives of the above compounds in which the carboxyl group at the 3- position is protected by an easily removable ester protecting group. The compounds of the present invention are of use as intermediates in the preparation of penem compounds having potent antibacterial activity.
SE8405812A 1978-12-18 1984-11-19 INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM COMPOUNDS SE8405812D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96866378A 1978-12-18 1978-12-18

Publications (2)

Publication Number Publication Date
SE8405812L true SE8405812L (en) 1984-11-19
SE8405812D0 SE8405812D0 (en) 1984-11-19

Family

ID=25514601

Family Applications (5)

Application Number Title Priority Date Filing Date
SE7910391A SE448995B (en) 1978-12-18 1979-12-17 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM SOCIETIES AND PROCEDURES FOR PREPARING THEREOF
SE7910390A SE454779B (en) 1978-12-18 1979-12-17 2,6-DISUBSTITUTED PENEM SOCIETIES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION THEREOF WITH ANTIBACTERIAL EFFECT
SE8405719A SE461395B (en) 1978-12-18 1984-11-14 4- (2'-AZIDOETOXIACETYLTIO) -1- (2 '-TRIFENYLFOSFORANYLIDEN-2 "-acetate) -2-azetidinones
SE8405813A SE464027B (en) 1978-12-18 1984-11-19 INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM SOCIETIES
SE8405812A SE8405812D0 (en) 1978-12-18 1984-11-19 INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM COMPOUNDS

Family Applications Before (4)

Application Number Title Priority Date Filing Date
SE7910391A SE448995B (en) 1978-12-18 1979-12-17 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM SOCIETIES AND PROCEDURES FOR PREPARING THEREOF
SE7910390A SE454779B (en) 1978-12-18 1979-12-17 2,6-DISUBSTITUTED PENEM SOCIETIES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION THEREOF WITH ANTIBACTERIAL EFFECT
SE8405719A SE461395B (en) 1978-12-18 1984-11-14 4- (2'-AZIDOETOXIACETYLTIO) -1- (2 '-TRIFENYLFOSFORANYLIDEN-2 "-acetate) -2-azetidinones
SE8405813A SE464027B (en) 1978-12-18 1984-11-19 INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM SOCIETIES

Country Status (13)

Country Link
JP (1) JPS60222486A (en)
AU (4) AU541717B2 (en)
CA (2) CA1286661C (en)
CH (2) CH643265A5 (en)
DK (5) DK533879A (en)
ES (1) ES8101594A1 (en)
FI (2) FI69845C (en)
GR (2) GR81420B (en)
IE (3) IE49877B1 (en)
IL (2) IL58576A (en)
SE (5) SE448995B (en)
YU (4) YU43628B (en)
ZA (2) ZA796812B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8509180D0 (en) * 1985-04-10 1985-05-15 Erba Farmitalia Penem derivatives
US4826832A (en) * 1986-05-06 1989-05-02 Ciba-Geigy Corporation Penen compounds
HUP9602872A3 (en) * 1995-02-17 1999-03-01 Daiichi Asubio Pharma Co Ltd Penem derivatives and antimicrobial agent containing the same
CN1133428C (en) 1998-01-13 2004-01-07 第一三得利制药株式会社 Antibacterial composition for topical administration containing antibiotics
JP2005239696A (en) 2004-01-30 2005-09-08 Daiichi Suntory Pharma Co Ltd Medicinal hard capsule preparation blended with inorganic substance
CN112746066B (en) * 2021-01-25 2023-10-31 洛阳华荣生物技术有限公司 L-lysine decarboxylase mutant and application thereof

Also Published As

Publication number Publication date
SE464027B (en) 1991-02-25
SE8405813D0 (en) 1984-11-19
DK135291A (en) 1991-07-15
YU215782A (en) 1983-06-30
AU541717B2 (en) 1985-01-17
YU43280B (en) 1989-06-30
ES487034A0 (en) 1980-12-16
DK236590D0 (en) 1990-10-01
AU5371079A (en) 1980-06-26
JPS60222486A (en) 1985-11-07
SE461395B (en) 1990-02-12
DK533779A (en) 1980-06-19
ZA796812B (en) 1981-05-27
DK161520C (en) 1991-12-23
FI69845C (en) 1986-05-26
CA1268183A (en) 1990-04-24
AU5378779A (en) 1980-08-28
FI69845B (en) 1985-12-31
DK533879A (en) 1980-06-19
DK161520B (en) 1991-07-15
DK135291D0 (en) 1991-07-15
SE8405812D0 (en) 1984-11-19
FI67853C (en) 1985-06-10
IL58576A (en) 1985-12-31
DK237690D0 (en) 1990-10-01
CH643265A5 (en) 1984-05-30
DK236590A (en) 1990-10-01
IE49876B1 (en) 1986-01-08
SE8405813L (en) 1984-11-19
IE50597B1 (en) 1986-05-28
YU42125B (en) 1988-04-30
IE49877B1 (en) 1986-01-08
FI793903A (en) 1980-06-19
GR81420B (en) 1984-12-11
GR74491B (en) 1984-06-28
AU3240884A (en) 1984-12-13
FI67853B (en) 1985-02-28
CH643846A5 (en) 1984-06-29
DK237690A (en) 1990-10-01
IL58576A0 (en) 1980-01-31
YU276079A (en) 1983-02-28
DK161970B (en) 1991-09-02
YU43464B (en) 1989-08-31
SE7910391L (en) 1981-06-18
CA1286661C (en) 1991-07-23
YU215382A (en) 1983-06-30
SE7910390L (en) 1981-06-18
ES8101594A1 (en) 1980-12-16
SE8405719L (en) 1984-11-14
IE792462L (en) 1980-06-18
IE852246L (en) 1980-06-18
ZA796813B (en) 1981-05-27
AU563015B2 (en) 1987-06-25
SE448995B (en) 1987-03-30
AU3288484A (en) 1985-03-07
YU43628B (en) 1989-10-31
SE454779B (en) 1988-05-30
IL58804A0 (en) 1980-02-29
YU307679A (en) 1983-02-28
IL58804A (en) 1986-03-31
DK161970C (en) 1992-02-03
AU539983B2 (en) 1984-10-25
SE8405719D0 (en) 1984-11-14
FI793905A (en) 1980-06-19
AU557545B2 (en) 1986-12-24
IE851853L (en) 1980-06-18

Similar Documents

Publication Publication Date Title
ES8105001A1 (en) Benzimidazoles, their preparation and pharmaceutical compositions containing them.
SE7907811L (en) AZETIDINYL COMPOUND FOR THE PREPARATION OF CEFEM COMPOUNDS AND PROCEDURE FOR ITS PREPARATION
FI842987A0 (en) NYA 1,8-NAPHTHYRIDINE DERIVATIVES AND FARMS FOR FRAMSTAELLNING.
IE41528L (en) Furfuryl-benzomorphane derivatives.
MY101801A (en) Novel phenoxyacetic acid derivatives, process for preparing the same and pharmaceutical composition having the same as an active ingredient.
ES8506629A1 (en) Pyridine derivatives.
SE7710873L (en) NEW 1H-PYRAZOLO (3,4-B) PYRIDINES
SE8405812L (en) INTERMEDIATES FOR THE PREPARATION OF NEW 2-SUBSTITUTED AND 2,6-DISUBSTITUTED PENEM COMPOUNDS
SE7906011L (en) NEW IMIDAZOKINOXALINES AND SALTS THEREOF, SET FOR PREPARATION AND USE THEREOF AS A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
ES8301971A1 (en) Derivatives of substituted N-alkylimidazoles, their preparation and pharmaceutical compositions containing them.
NO995935D0 (en) 17 &lt;beta&gt; -alloxy (thio) alkyl-androstane derivatives for modulating meiosis
SE8305917D0 (en) INTERMEDIATES FOR USE IN THE PREPARATION OF HEXAHYDRO-GAMMA CARBOL COMPOUNDS
ES8203870A1 (en) Diphenylbutyl-1-acylpiperazines.
ES442217A1 (en) 1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections
ES456400A1 (en) Thienothiazine derivatives
FI853866A0 (en) 2-PYRIDIN-THIOL DERIVATIVES, FOERFARANDE FOER FRAMSTAELLNING AV DESSA SAMT PHARMACEUTICAL FOERENINGAR INNEHAOLLANDE DESSA.
ES8101646A1 (en) Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions.
ES475004A1 (en) Derivatives of clavulanic acid and pharmaceutical compositions containing them.
KR860007264A (en) Method for preparing new 1-oxa-1-dethia cephalosporin compound
SE8703494D0 (en) INTERMEDIATES USEFUL IN THE PREPARATION OF 2-THIOFENEETIC ACETIC ACID DERIVATIVES
FI943644A (en) New acid anhydrides, their preparation and use
ES8103742A2 (en) 1,3-Benzodioxin derivatives
ES459705A1 (en) Acylated hydrazinopyridazine antihypertensives
ES8304532A1 (en) Therapeutically active derivatives of phenylethanol amines.
SE7910387L (en) 7ALFA METOXICE PHALOSPORINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8405812-2